<img alt="" height="1" width="1" />
FDA approves Glaxo combo vaccine for seniors
BusinessWeek
The Food and Drug Administration said Friday it approved GlaxoSmithKline's combination vaccine Boostrix for a new use in patients 65 and older. Boostrix offers protection against tetanus, diphtheria and whooping cough. It was previously approved as a ...
FDA approves GSK's Boostrix vaccine for older peopleReuters
FDA Approves Tdap Booster for SeniorsMedscape
Concerned educators push whooping cough vaccineBakersfield Californian
Internal Medicine News Digital Network -Scottsboro Daily Sentinel -NASDAQ
all 189 news articles »
More...